Leaders in Pharmaceutical Business Intelligence (LPBI) Group

About 13th Annual Biotech in Europe Investor Forum

The 13th Annual Biotech in Europe Investor Forum will be held on 30^th September – 1^st October 2013 in the Hilton Zurich Airport Hotel, Switzerland. The forum is recognised as the leading international stage for those interested in investing in the biotech and life science industry and is highly transactional, drawing together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharmas. Supported and designed by leading figures within Europe’s bio industry, this event will once again be covered by our regular media partners. We expect around 350 delegates and 80 presenting companies.

The two-day conference programme will give you access to some of the leading players in the industry and will provide you with truly excellent networking opportunities as it boasts an online partnering system with 500 meeting slots available for all attendees to book before the event.

The program will comprise of plenary panels including:

• Public Markets and M&A
• Investment
• Platform Technologies and Novel Therapeutics
• Oncology
• Vaccines
• Neuroscience
• Partnering
• Medtech & Device
• Diagnostics
• Emerging Companies

Speakers & Chairs confirmed for the event include:

• Anthony Rosenberg, Head, Partnering & Emerging Businesses, Novartis Pharma AG
• Bernd Goergen, Senior Investment Manager, High-Tech Gründerfonds Management
• Carole Nuechterlein, Head, Roche Venture Fund
• Deborah Harland, General Partner, SR One
• Douglas Famborough, CEO, Dicerna Pharmaceuticals
• Esteban Pombo-Villar, COO, Oxford BioTherapeutics
• Fintan Walton, Founder and CEO, PharmaVentures Ltd.
• Florian Schoedel, CEO, Phillimune LLC
• Frank Grams, Head Alliance Management & Contracting, Sanofi R&D
• Genghis Lloyd-Harris, Partner, Abingworth Management
• Graeme Martin, President and CEO, Takeda Research Investment, Inc.
• Hans Christinger, Director Licensing and Acquisitions, Abbot Laboratories
• Heinz Schwer, Senior Director, MorphoSys AG
• Judith Hills, Vice President Corporate Business Development, Ipsen Biopharm Ltd
• Katya Smirnyagina, Venture Partner, Capricorn Venture Partners
• Klaus Langner, Executive Vice President and Chief Operating Officer, Grunenthal Innovations,Grunenthal
• Margarita Chavez, Director, Abbott Biotech Ventures
• Markus Hosang, General Partner, BioMedPartners
• Martine Kaufmann, Managing Director, Martina Kaufmann Strategic Consulting
• Naveed Siddiqi, Partner, Phase4 Ventures Limited
• Oliver Middendorp, Chief Business Officer, Numab AG
• Philippe Calais, CEO, Antisense Pharma GmbH
• Rafaèle Tordjman, Partner, Sofinnova Partners
• Rainer Strohmenger, Partner, Life Sciences, Wellington Partners
• Sarah Holland, Global Head, Strategic Partnering, Roche Partnering
• Thomas Kronbach, CEO, Biocrea GmbH
• Vincent Charlon, CEO, Anergis
• Wilder Fulford, Principal, Torreya Partners
• Willem van Weperen, CEO, To-BBB Technologies BV
• And More TBA…

NEW FOR 2013:
Personalised Medicine and Companion Diagnostics:
from development to market.

A series of lectures and panels covering;

• Regulation
• Clinical trials design
• Pharma interaction
• Market access & Reimbursement

Confirmed speakers include:

• Eddie Blair, CEO, Integrated Magnetic Systems Ltd.
• Lorenza Castellon, Health and Biotech Equity Analyst, Equity Development Ltd.
• Martina Kaufmann, Managing Director, Martina Kaufmann Strategic Consulting

Presenting Opportunities

Presenting at the forum offers excellent opportunities to showcase your company to some of the leading global investors and corporates. It will offer you the opportunity to communicate your projected capital raising plans or simply help you in finding the right partner for your business.

Presenting companies from Europe and the US will benefit from specially designed panels and keynote addresses from leading industry figures as well as access to some of the leading analysts and investors from Europe and beyond. This year, we aim to expand the audience and provide once again, opportunities for executive-level networking, deal-making and strategic partnering.

The forum is recognised as the leading international stage for those interested in investing in the biotech and life science industry and is highly transactional, drawing together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharmas. Supported and designed by leading figures within Europe’s bio industry, this event will once again be covered by our regular media partners.

Sponsorship

Sachs Associates has developed an extensive knowledge of the key individuals operating within the European and global biotech industry. This together with a growing reputation for excellence puts Sachs Associates at the forefront of the industry and provides a powerful tool by which to increase the position of your company in this market.

Raise your company’s profile directly with your potential clients. All of our sponsorship packages are tailor made to each client, allowing your organisation to gain the most out of attending our industry driven events.

To learn more about presenting, exhibition or sponsorship opportunities, please contact
Zoe Harris + 44 (0)203 463 4890 or by email: Zoe Harris.